Decreased risk of cholangiocarcinoma in diabetic patients treated with metformin
Conclusion: The results show a slight decreased risk of cholangiocarcinoma in that scenario.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Pathum Sookaromdee Viroj Wiwanitkit Source Type: research
More News: Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Diabetes | Diabetes Mellitus | Endemics | Endocrinology | Fortamet | Men | Metformin | Study | Thailand Health